1 |
Grim C, Noble R, Uribe G, Khanipov K, Johnson P, Koltun WA, Watts T, Fofanov Y, Yochum GS, Powell DW, Beswick EJ, Pinchuk IV. Impairment of Tissue-Resident Mesenchymal Stem Cells in Chronic Ulcerative Colitis and Crohn's Disease. J Crohns Colitis 2021;15:1362-75. [PMID: 33506258 DOI: 10.1093/ecco-jcc/jjab001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
2 |
López-Beas J, Guadix JA, Clares B, Soriano-Ruiz JL, Zugaza JL, Gálvez-Martín P. An overview of international regulatory frameworks for mesenchymal stromal cell-based medicinal products: From laboratory to patient. Med Res Rev 2020;40:1315-34. [PMID: 32017179 DOI: 10.1002/med.21659] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
3 |
Fawzy El-Sayed KM, Ahmed GM, Abouauf EA, Schwendicke F. Stem/progenitor cell-mediated pulpal tissue regeneration: a systematic review and meta-analysis. Int Endod J 2019;52:1573-85. [PMID: 31232460 DOI: 10.1111/iej.13177] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
|
4 |
Fellous T, De Maio F, Kalkan H, Carannante B, Boccella S, Petrosino S, Maione S, Di Marzo V, Iannotti FA. Phytocannabinoids promote viability and functional adipogenesis of bone marrow-derived mesenchymal stem cells through different molecular targets. Biochemical Pharmacology 2020;175:113859. [DOI: 10.1016/j.bcp.2020.113859] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
|
5 |
Hartwig O, Shetab Boushehri MA, Shalaby KS, Loretz B, Lamprecht A, Lehr CM. Drug delivery to the inflamed intestinal mucosa - targeting technologies and human cell culture models for better therapies of IBD. Adv Drug Deliv Rev 2021;175:113828. [PMID: 34157320 DOI: 10.1016/j.addr.2021.113828] [Reference Citation Analysis]
|
6 |
Yang J, Ren XJ, Chen XT, Jiang YF, Han ZB, Han ZC, Li XR, Zhang XM. Human umbilical cord-derived mesenchymal stem cells treatment for refractory uveitis: a case series. Int J Ophthalmol 2021;14:1784-90. [PMID: 34804871 DOI: 10.18240/ijo.2021.11.20] [Reference Citation Analysis]
|
7 |
Ocansey DKW, Wang L, Wang J, Yan Y, Qian H, Zhang X, Xu W, Mao F. Mesenchymal stem cell-gut microbiota interaction in the repair of inflammatory bowel disease: an enhanced therapeutic effect. Clin Transl Med 2019;8:31. [PMID: 31872304 DOI: 10.1186/s40169-019-0251-8] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 5.3] [Reference Citation Analysis]
|
8 |
Bidkhori HR, Bahrami AR, Farshchian M, Heirani-Tabasi A, Mirahmadi M, Hasanzadeh H, Ahmadiankia N, Faridhosseini R, Dastpak M, Shabgah AG, Matin MM. Mesenchymal Stem/Stromal Cells Overexpressing CXCR4R334X Revealed Enhanced Migration: A Lesson Learned from the Pathogenesis of WHIM Syndrome. Cell Transplant 2021;30:9636897211054498. [PMID: 34807749 DOI: 10.1177/09636897211054498] [Reference Citation Analysis]
|
9 |
Liu X, Miramini S, Patel M, Liao J, Shidid D, Zhang L. Balance Between Mechanical Stability and Mechano-Biology of Fracture Healing Under Volar Locking Plate. Ann Biomed Eng 2021. [PMID: 34189632 DOI: 10.1007/s10439-021-02815-x] [Reference Citation Analysis]
|
10 |
Ocansey DKW, Qiu W, Wang J, Yan Y, Qian H, Zhang X, Xu W, Mao F. The Achievements and Challenges of Mesenchymal Stem Cell-Based Therapy in Inflammatory Bowel Disease and Its Associated Colorectal Cancer. Stem Cells Int 2020;2020:7819824. [PMID: 32256612 DOI: 10.1155/2020/7819824] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
|
11 |
Zhao LX, Zhang K, Shen BB, Li JN. Mesenchymal stem cell-derived exosomes for gastrointestinal cancer. World J Gastrointest Oncol 2021; 13(12): 1981-1996 [DOI: 10.4251/wjgo.v13.i12.1981] [Reference Citation Analysis]
|
12 |
Lee OJ, Luk F, Korevaar SS, Koch TG, Baan CC, Merino A, Hoogduijn MJ. The Importance of Dosing, Timing, and (in)Activation of Adipose Tissue-Derived Mesenchymal Stromal Cells on Their Immunomodulatory Effects. Stem Cells and Development 2020;29:38-48. [DOI: 10.1089/scd.2019.0225] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
|
13 |
Fu H, Chu D, Geng X. Downregulation of miR-17 suppresses TGF-β1-mediated renal fibrosis through targeting Smad7. Mol Cell Biochem 2021;476:3051-64. [PMID: 33797702 DOI: 10.1007/s11010-021-04140-2] [Reference Citation Analysis]
|
14 |
Li JN, Li W, Cao LQ, Liu N, Zhang K. Efficacy of mesenchymal stem cells in the treatment of gastrointestinal malignancies. World J Gastrointest Oncol 2020; 12(4): 365-382 [PMID: 32368316 DOI: 10.4251/wjgo.v12.i4.365] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|